Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.
Statistics

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds

Lemon juice and human norovirus

No. 38 | 25/08/2015 | by Koh

Citric acid may prevent the highly contagious norovirus from infecting humans, scientists discovered from the German Cancer Research Center. Therefore, lemon juice could be a potentially safe and practical disinfectant against the most common pathogen of severe gastrointestinal infections.

Picture: Jorgebarrios, Wikimedia Commons

Noroviruses are the predominant cause of gastroenteritis outbreaks in community settings such as hospitals, cruise ships, and schools. The virus is extremely contagious and is mostly transmitted via "fecal-oral-route", i.e., through contaminated hands or contaminated food. Symptoms include violent and sudden onset of diarrhea, vomiting, and nausea.

"It is therefore important to provide a safe and harmless disinfectant against human norovirus," explains Grant Hansman, head of CHS junior research group at the German Cancer Research Center noroviruses and the University of Heidelberg. The group is funded by the CHS Foundation. Some older observations found that fruit extracts, such as orange or pomegranate juice, could reduce the infectivity of surrogate noroviruses.

This current study was a continuation of an earlier project conducted at the National Institutes of Health in the United States, where they discovered that citrate from a commercial company could bind to the norovirus capsid protein. "However, it was only by chance that this discovery was made, like a lot of scientific research, but it turns out to be very interesting." Dr Hansman explains.

Human noroviruses does not grow in cell culture, so they tested the effects of increasing concentrations of citric buffer on the so called norovirus virus-like particles, which have the same surface characteristics as real viruses. Dr Hansman and his staff show that the virus particles change their shape after citrate binding. X-ray crystal structures revealed that the citrate - from lemon juice or citrate disinfectants - precisely interacts at the binding pocket on the particle that is involved in attaching to host ligands – the so-called histo-blood group antigens.

These new results may explain why citrate reduces the infectivity of noroviruses. "Maybe a few drops of lemon juice on contaminated food or surfaces may prevent the transmission of these viruses," speculates Hansman. With his staff, he now plans to investigate if citric acid could reduce symptoms in those already infected with noroviruses.

Anna D. Koromyslova, Peter White, and Grant S. Hansman: Citrate alters norovirus particle morphology. Virology 2015, DOI: 10.1016/j.virol.2015.07.009

The German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) with its more than 3,000 employees is the largest biomedical research institution in Germany. More than 1,300 scientists at the DKFZ investigate how cancer develops, identify cancer risk factors and search for new strategies to prevent people from developing cancer. They are developing new methods to diagnose tumors more precisely and treat cancer patients more successfully. The DKFZ's Cancer Information Service (KID) provides patients, interested citizens and experts with individual answers to all questions on cancer.

Jointly with partners from the university hospitals, the DKFZ operates the National Center for Tumor Diseases (NCT) in Heidelberg and Dresden, and the Hopp Children's Cancer Center KiTZ in Heidelberg. In the German Consortium for Translational Cancer Research (DKTK), one of the six German Centers for Health Research, the DKFZ maintains translational centers at seven university partner locations. NCT and DKTK sites combine excellent university medicine with the high-profile research of the DKFZ. They contribute to the endeavor of transferring promising approaches from cancer research to the clinic and thus improving the chances of cancer patients.

The DKFZ is 90 percent financed by the Federal Ministry of Education and Research and 10 percent by the state of Baden-Württemberg. The DKFZ is a member of the Helmholtz Association of German Research Centers.

RSS-Feed

Subscribe to our RSS-Feed.

to top
powered by webEdition CMS